Related Experiment Video
Updated: Aug 9, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period
H Randall Griffith1, Kelli L Netson, Lindy E Harrell
1Department of Neurology, University of Alabama at Birmingham, 1216 Jefferson Tower, 625 19th Street South, Birmingham, AL, USA. rlgriffith@uabmc.edu
Abstract:
Amnestic mild cognitive impairment (MCI) has been defined as a precursor to Alzheimer's disease (AD), although it is sometimes difficult to identify which persons with MCI will eventually convert to AD. We sought to predict MCI conversion to AD over a two-year follow-up period using baseline demographic and neuropsychological test data from 49 MCI patients. Using a stepwise discriminant function analysis with Dementia Rating Scale (DRS) Initiation/Perseveration and Wechsler Memory Scale, third edition (WMS-III) Visual Reproduction Percent Retention scores, we correctly classified 85.7% of the sample as either AD converters or MCI nonconverters, with 76.9% sensitivity and 88.9% specificity. Adding race, the presence of vascular risk factors, or cholinesterase inhibitor use to the analysis did not greatly change the classification rates obtained with neuropsychological test data. Examining neuropsychological test cutoff scores revealed that DRS Initiation/Perseveration scores below 37 and Visual Reproduction Percent Retention scores below 26% correctly identified AD converters with 76.9% sensitivity and 91.7% specificity. These results demonstrate that commonly administered neuropsychological tests identify persons with MCI at baseline who are at risk for conversion to AD within 1-2 years. Such methods could aid in identifying MCI patients who might benefit from early treatment, in providing prognostic information to patients, and identifying potential clinical trial participants.
Insights
Neuropsychological tests can predict Alzheimer's disease (AD) progression in individuals with mild cognitive impairment (MCI). Specific scores on the Dementia Rating Scale and Wechsler Memory Scale accurately identify those at high risk for conversion to AD.
Area of Science:
- Neurology
- Neuropsychology
- Gerontology
Background:
- Amnestic mild cognitive impairment (MCI) is a known precursor to Alzheimer's disease (AD).
- Accurately identifying MCI patients who will progress to AD is challenging but crucial for timely intervention.
- Early detection of MCI conversion to AD aids in treatment planning and clinical trial recruitment.
Purpose of the Study:
- To predict the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD) within a two-year timeframe.
- To evaluate the efficacy of baseline demographic and neuropsychological data in predicting MCI to AD conversion.
- To establish specific neuropsychological test cutoff scores for identifying individuals at high risk for AD progression.
Main Methods:
- A cohort of 49 MCI patients was analyzed using baseline demographic and neuropsychological data.
- Stepwise discriminant function analysis was employed, focusing on Dementia Rating Scale (DRS) Initiation/Perseveration and Wechsler Memory Scale, third edition (WMS-III) Visual Reproduction Percent Retention scores.
- Classification rates, sensitivity, and specificity were calculated to assess predictive accuracy.
Main Results:
- The analysis correctly classified 85.7% of MCI patients as converters or non-converters to AD.
- High sensitivity (76.9%) and specificity (88.9%) were achieved using DRS and WMS-III scores.
- Specific cutoff scores (DRS < 37, WMS-III < 26%) demonstrated high accuracy in identifying AD converters (76.9% sensitivity, 91.7% specificity).
- Demographic factors and vascular risk did not significantly improve predictive accuracy.
Conclusions:
- Commonly administered neuropsychological tests can effectively identify MCI patients at risk for conversion to AD within 1-2 years.
- These findings support the use of neuropsychological assessments for prognostic information and early treatment targeting in MCI.
- The study highlights the potential of these methods for identifying suitable participants for Alzheimer's disease clinical trials.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Cognitive Development During Adulthood
Dementia l: Introduction
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Dementia
The progression of dementia is generally gradual.

